Science Explorer Back to mapMap

Most cited papers in Migraine and Headache Studies

What are the most cited papers in Migraine and Headache Studies?

The most cited paper in Migraine and Headache Studies is "The International Classification of Headache Disorders: 2nd edition" (Jes Olesen, Peter James Goadsby, Tim Steiner, 2003), with 5,056 citations. Next come "Interplay between Cortical Spreading Depolarization and Seizures" (3,708) and "The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide" (2,483).

Showing 50 of 100 papers. Every paper with more than 662 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The International Classification of Headache Disorders: 2nd edition Jes Olesen, Peter James Goadsby, Tim Steiner · The Lancet Neurology 20 Nov 2003 5,056
2 Interplay between Cortical Spreading Depolarization and Seizures Daniel R. Kramer, Tatsuhiro Fujii, Ifije E. Ohiorhenuan et al. · Stereotactic and Functional Neurosurgery 2017 3,708
3 The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide LJ Stovner, Knut Hagen, Rigmor Jensen et al. · Cephalalgia Mar 2007 2,483
4 Migraine prevalence, disease burden, and the need for preventive therapy Richard B. Lipton, MARCELO EDUARDO BIGAL, Merle L. Diamond et al. · Neurology Open access 30 Jan 2007 2,375
5 Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations Neil K. Aaronson, Martín Müller, Peter D. A. Cohen et al. · Journal of Clinical Epidemiology Nov 1998 2,328
6 The International Classification of Headache Disorders Jes Olesen · Headache The Journal of Head and Face Pain Open access May 2008 2,327
7 Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II Richard B. Lipton, Walter F. Stewart, Seymour Diamond et al. · Headache The Journal of Head and Face Pain 12 Jul 2001 2,285
8 Pathophysiology of Migraine: A Disorder of Sensory Processing Peter James Goadsby, Philip Robert Holland, Margarida Martins-Oliveira et al. · Physiological Reviews ReviewOpen access 8 Feb 2017 2,059
9 Migraine — Current Understanding and Treatment Peter James Goadsby, Richard B. Lipton, Michel D. Ferrari · New England Journal of Medicine 24 Jan 2002 1,936
10 Vasoactive peptide release in the extracerebral circulation of humans during migraine headache Peter James Goadsby, Lars IH Edvinsson, Rolf Ekman · Annals of Neurology Aug 1990 1,622
11 Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache Stephen Morley, Christopher Eccleston, Amanda C de C Williams · Pain Review Mar 1999 1,600
12 Mechanisms of migraine aura revealed by functional MRI in human visual cortex Nouchine K. Hadjikhani, Margarita Sánchez del Río, Ona Wu et al. · Proceedings of the National Academy of Sciences Open access 3 Apr 2001 1,536
13 Prevalence of Migraine Headache in the United States Walter F. Stewart · JAMA 1992 1,514
14 VISUAL CAPACITY IN THE HEMIANOPIC FIELD FOLLOWING A RESTRICTED OCCIPITAL ABLATION Lawrence Weiskrantz, Elizabeth K. Warrington, M. D. Sanders et al. · Brain 1974 1,477
15 Epidemiology of headache in a general population—A prevalence study Birthe Krogh Rasmussen, Rigmor Jensen, Marianne Schroll et al. · Journal of Clinical Epidemiology 1991 1,476
16 The Long-Term Outcome of Microvascular Decompression for Trigeminal Neuralgia Fred G. Barker, Peter J. Jannetta, David J. Bissonette et al. · New England Journal of Medicine 25 Apr 1996 1,444
17 Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016 Marom Bikson et al. · Brain stimulation Open access 17 Jun 2016 1,438
18 Brain stem activation in spontaneous human migraine attacks Cornelius Weiller, Arne May, Volker Limmroth et al. · Nature Medicine Jul 1995 1,393
19 A six-item short-form survey for measuring headache impact: The HIT-6™ Mark R. Kosinski, Martha S. Bayliss, Jakob Bue Bjørner et al. · Quality of Life Research 3 Nov 2003 1,389
20 Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) [RETIRED] Stephen David Silberstein · Neurology Open access 26 Sep 2000 1,371
21 How common are the “common” neurologic disorders? Deborah Hirtz, David J. Thurman, Katrina Gwinn et al. · Neurology 30 Jan 2007 1,367
22 Calcitonin Gene-Related Peptide: Physiology and Pathophysiology Fiona Anne Russell, Ross King, S-J Smillie et al. · Physiological Reviews ReviewOpen access Oct 2014 1,291
23 Cardiovascular effects of human insular cortex stimulation S. M. Oppenheimer, Adrian W. Gelb, J P Girvin et al. · Neurology Sep 1992 1,276
24 Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model Hayrünnisa Bolay, Uwe Reuter, Andrew K. Dunn et al. · Nature Medicine Feb 2002 1,229
25 Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine Jes Olesen, Hans‐Christoph Diener, Ingo Wilhelm Husstedt et al. · New England Journal of Medicine Open access 10 Mar 2004 1,188
26 The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats Peter James Goadsby, Lars IH Edvinsson · Annals of Neurology 1993 1,172
27 Pathophysiology of the migraine aura Martin Lauritzen · Brain 1994 1,155
28 Cost of disorders of the brain in Europe Patrik Andlin‐Sobocki, Bengt Jönsson, Hans‐Ulrich Wïttchen et al. · European Journal of Neurology 5 May 2005 1,148
29 Hypothalamic activation in cluster headache attacks Arne May, Anish Bahra, Christian Büchel et al. · The Lancet Jul 1998 1,130
30 Vestibular migraine: Diagnostic criteria Thomas Lempert, Jes Olesen, JOSEPH M. R. FURMAN et al. · Journal of Vestibular Research Open access Nov 2012 1,120
31 THE ROLE OF EARLY LEFT‐BRAIN INJURY IN DETERMINING LATERALIZATION OF CEREBRAL SPEECH FUNCTIONS Theodore P. Rasmussen, Brenda Atkinson Milner · Annals of the New York Academy of Sciences Sep 1977 1,117
32 Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019 on behalf of Lifting The Burden: the Global Campaign against Headache, Timothy J. Steiner, Lars Jacob Stovner et al. · The Journal of Headache and Pain Open access Dec 2020 1,113
33 Cgrp May Play A Causative Role in Migraine LH Lassen, P. A. Haderslev, V. B. Jacobsen et al. · Cephalalgia Feb 2002 1,058
34 OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial SK Aurora, DW Dodick, CC Turkel et al. · Cephalalgia Open access 17 Mar 2010 1,058
35 CGRP as the target of new migraine therapies — successful translation from bench to clinic Lars IH Edvinsson, Kristian Agmund Haanes, Karin Warfvinge et al. · Nature Reviews Neurology ReviewOpen access 24 Apr 2018 1,036
36 An association between migraine and cutaneous allodynia Rami Burstein, David Yarnitsky, Itay Goor‐Aryeh et al. · Annals of Neurology May 2000 1,033
37 The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients Anne Ducros, Monique Boukobza, Raphaël Porcher et al. · Brain 3 May 2007 1,013
38 OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse et al. · Headache The Journal of Head and Face Pain 7 May 2010 1,006
39 Migraine as a Risk Factor for Subclinical Brain Lesions Mark C. Kruit · JAMA 27 Jan 2004 1,004
40 Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials Michel D. Ferrari, Krista I Roon, Richard B. Lipton et al. · The Lancet Review Nov 2001 992
41 A Controlled Trial of Erenumab for Episodic Migraine Peter James Goadsby, Uwe Reuter, Yngve Hallström et al. · New England Journal of Medicine Open access 24 Nov 2017 977
42 OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial HC Diener, DW Dodick, SK Aurora et al. · Cephalalgia 17 Mar 2010 973
43 Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2 Maurizio De Fusco, Roberto Marconi, Laura Silvestri et al. · Nature Genetics 21 Jan 2003 954
44 Narrative Review: Reversible Cerebral Vasoconstriction Syndromes Leonard H. Calabrese, David W. Dodick, Todd J. Schwedt et al. · Annals of Internal Medicine Review 2 Jan 2007 954
45 The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates Lars Jacob Stovner, Knut Hagen, Mattias Linde et al. · The Journal of Headache and Pain Open access 11 Apr 2022 937
46 Burden of Migraine in the United States Xiaohan Hu, Leona E. Markson, Richard B. Lipton et al. · Archives of Internal Medicine Open access 26 Apr 1999 919
47 The neurobiology of vascular head pain Michael A. Moskowitz · Annals of Neurology Aug 1984 918
48 New Appendix Criteria Open for a Broader Concept of Chronic Migraine Jes Olesen, M.G. Bousser, H-C Diener et al. · Cephalalgia 10 May 2006 917
49 Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Stephen D. Silberstein, Starr Holland, F. G. Freitag et al. · Neurology Open access 23 Apr 2012 910
50 EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force Stefan Evers, Judit Áfra, Achim Frese et al. · European Journal of Neurology 7 Aug 2009 899

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.